Research field (PhD, 2018-): Minimal invasive disease detection and monitoring in follicular lymphoma (1st Dpt. of Pathology and Experimental Cancer Research, Semmelweis University)
Research field (Medical School, 2014-2017): Investigation of energy homeostasis in the centrally projecting Edinger-Westphal Nucleus (Dpt. of Anatomy, University of Pécs, Medical School)
Conferences (PhD):
Conferences (Medical School):
Workshop attendance:
Editorial activity
Teaching activity
Mentoring medical school student’s
Furedi, N.; Nagy, A.; Miko, A.; Berta, G.; Kozicz, T.; Petervari, E.; Balasko, M.; Gaszner, B. Neuropharmacology 2017, 118, 26-37, doi:10.1016/j.neuropharm.2017.03.002.
Gango, A.; Alpar, D.; Galik, B.; Marosvari, D.; Kiss, R.; Fesus, V.; Aczel, D.; Eyupoglu, E.; Nagy, N.; Nagy, A.; Krizsan, S.; Reiniger, L.; Farkas, P.; Kozma, A.; Adam, E.; Tasnady, S.; Reti, M.; Matolcsy, A.; Gyenesei, A.; Matrai, Z.; Bodor, C. Int J Cancer 2020, 146, 85-93, doi:10.1002/ijc.32502.
Bodor, C.; Alpar, D.; Marosvari, D.; Galik, B.; Rajnai, H.; Batai, B.; Nagy, A.; Kajtar, B.; Burjan, A.; Deak, B.; Schneider, T.; Alizadeh, H.; Matolcsy, A.; Brandner, S.; Storhoff, J.; Chen, N.; Liu, M.; Ghali, N.; Csala, I.; Bago, A.G.; Gyenesei, A.; Reiniger, L. J Neuropathol Exp Neurol 2020, 79, 176-183, doi:10.1093/jnen/nlz125.
Nagy, A.; Batai, B.; Balogh, A.; Illes, S.; Mikala, G.; Nagy, N.; Kiss, L.; Kotmayer, L.; Matolcsy, A.; Alpar, D.; Masszi, T.; Masszi, A.; Bodor, C. Genes (Basel) 2020, 11, doi:10.3390/genes11070785.
Schvarcz, C.A.; Danics, L.; Krenacs, T.; Viana, P.; Beres, R.; Vancsik, T.; Nagy, A.; Gyenesei, A.; Kun, J.; Fonovic, M.; Vidmar, R.; Benyo, Z.; Kaucsar, T.; Hamar, P. Cancers (Basel) 2021, 13, doi:10.3390/cancers13071744.
Fésüs, V.; Nagy, Á.; Alpár, D.; Bödör, C. Hematológia–Transzfuziológia 2019, 52, 178, doi:10.1556/2068.2019.52.3.4.
Nagy, Á.; Bátai, B.; Kiss, L.; Marx, A.; Pinczés, L.I.; Papp, G.; Kacskovics, I.; Alpár, D.; Bödör, C. Hematológia–Transzfuziológia 2020, 53, 144, doi:10.1556/2068.2020.53.3.3.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 739593. HCEMM supported by EU Programme: H2020-EU.4.a. – Teaming of excellent research institutions and low performing RDI regions. Project starting date was 1 April 2017.